Search

everythinglearnresearchcommunity

for

Search:↓

A patient had skin tissue death at the hair removal site after a hair transplant, which was treated with surgery.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Suppressing certain hormones might help prevent prostate cancer.

Annurca apple supplement safely increases hair growth and keratin in humans.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Certain transporters are found in human hair follicles and may affect hair growth and loss.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Stem cell differentiation is crucial for skin barrier maintenance and its disruption can lead to skin diseases.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Finasteride may improve prostate cancer treatment outcomes.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New drugs are improving treatment for hormone-related diseases in small pets.

The four main causes of hair loss in children are fungal infections, pulling out hair, autoimmune hair loss, and stress-related hair shedding.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.